The negative trailing multiple reflects near-zero or negative reported net margins across most of the ten quarters, so it carries little information about value on its own. The forward P/E of 20.24 and forward EV/EBITDA of 12.82 imply that investors are underwriting a substantial improvement in operating leverage, which the 6.0% operating margin in 2026Q3 only partially supports. Compared with peer Check Point at 15.40 trailing P/E and Qualys at 36.70, TENB's forward multiples appear moderate, but investors should monitor whether stock-based compensation keeps the gap between adjusted and GAAP earnings wide.

Gross margins have held steady between 77.5% and 78.8%, indicating pricing power is intact, so the constraint sits in operating expenses rather than cost of revenue. Net margin of 4.1% in 2026Q3 versus 6.0% operating margin shows that financing costs and other items still absorb a portion of operating profit. The gap versus peers suggests the recovery may be incomplete unless SG&A intensity falls meaningfully from its current level of roughly half of gross profit.

With equity pushed to negative territory by buybacks and accumulated deficits, ROE becomes mathematically unstable and should not be read as evidence of compounding returns. ROIC of 2.5% in 2026Q3 remains low in absolute terms and below Qualys at 47.5% and Check Point at 23.2%, indicating limited capital productivity. Investors should monitor whether ROIC can rise on operating earnings rather than on a shrinking capital base.

The debt-to-EBITDA multiple of 30.88 in 2026Q3 reflects how little reported EBITDA stands behind the debt, even after recent improvement. Debt-to-equity is no longer meaningful with negative equity, so coverage and debt quantum are the more informative measures. Refinancing risk and covenant headroom cannot be assessed from the supplied data, and that uncertainty warrants further investigation.